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DEMARCATE: Density-based MRI Clustering for 
Assessing Tumor Heterogeneity in Cancer
In this work, we examined MRI images from Glioblastoma
Multiforme (GBM) patients to assess image-based tumor
heterogeneity. Standard approaches are based on scalar
summary measures of histograms (e.g. quantiles) that do not
adequately capture the complete information in the voxel-level
data. We introduce a novel technique, DEMARCATE (DEnsity-
based MAgnetic Resonance image Clustering for Assessing
Tumor hEterogeneity) to explore the entire tumor heterogeneity
density profiles. Our analyses revealed two clusters of patients,
with marked differences in tumor morphology, genomic
characteristics and clinical outcome.
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MOTIVATION and AIMS
• Glioblastoma Multiforme (GBM) is the most common and
most aggressive malignant primary brain tumor.
• Tumor heterogeneity is a crucial area of cancer research
wherein inter- and intra-tumor differences are investigated for
assessing and monitoring disease progression.
• Imaging-based modalities allow for non-invasive techniques
to assess tumor heterogeneity.
DESCRIPTION OF DATA
Number of patients considered for study: 64
T1-weighted post contrast
+ =
T2-weighted FLAIR
+ =
Covariates:
Covariates:
Tumor subtypes – Classical, Mesenchymal, Neural, Proneural
Driver genes – DDIT3, EGFR, KIT, MDM4, PDGFRA, PIK3CA,
PTEN
METHODS RESULTS
DEMARCATE STATISTICAL  FRAMEWORK
Consider a smooth density representation of the histogram for
pixel intensity values corresponding to the tumor.
FISHER-RAO METRIC and REPRESENTATION SPACE OF
PROBABILITY DENSITY FUNCTIONS
The Fisher-Rao (FR) metric on is defined as:
for any point and the tangent vectors ,
Define square-root transform of probability density function:
CLUSTER ANALYSIS and VALIDATION
We utilize an intrinsic version of the k-means clustering technique
on . This approach partitions the space by minimizing the within-
cluster sum of the squared distances (using the FR metric) to the
assigned cluster centre.
For validation, consider a Bayesian version of Fisher’s Test.
y1 ~ Bin(n1, θ1)
y2 ~ Bin(n2, θ2)
Let θ1 ~ Unif(0,1) and θ2 ~ Unif(0,1) be priors for proportions.
Posterior Distribution: θi | yi ~ Beta (yi + 1, ni - yi + 1), i = 1, 2.
Use Monte Carlo approximation to calculate
Enrichment Probability:
Cluster 1 Cluster 2 TOTAL
A y1 n1-y1 n1
A’ y2 n2-y2 n2
T1-weighted post contrast Cluster 1: 24, Cluster 2: 40
T2-weighted FLAIR Cluster 1: 30, Cluster 2: 34
T1-weighted post contrast MR images for typical patients:
Cluster-wise survival times:
T1-weighted post contrast
T2-weighted FLAIR
1 = {high survival} + {Proneural} + {MDM4} + {young patients}
2 = {low survival} + {Classical, Neural} + {KIT, PTEN, DDIT3} +
{older patients}
Cl 1 Cl 2 Difference
Mean
Median
22.06
17.00
14.81
12.95
7.25
4.05
Cl 1 Cl 2 Difference
Mean
Median
20.27
16.60
15.11
13.45
5.16
3.15
CONCLUSION
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